Perfenazin

Perfenazin
Data klinis
AHFS/Drugs.commonograph
MedlinePlusa682165
Kategori
kehamilan
  • AU: C
Rute
pemberian		Oral dan intramuskular
Kelas obatAntipsikotik tipikal
Kode ATC
Status hukum
Status hukum
Data farmakokinetika
Bioavailabilitas40%
Metabolismehati
Waktu paruh eliminasi8–12 (hingga 20) jam
Pengenal
  • 2-[4-[3-(2-kloro-10H-fenotiazin-10-il) propil]piperazin-1-il]etanol
Nomor CAS
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.346 Sunting di Wikidata
Data sifat kimia dan fisik
RumusC21H26ClN3OS
Massa molar403,97 g·mol−1
Model 3D (JSmol)
  • Clc2cc1N(c3c(Sc1cc2)cccc3)CCCN4CCN(CCO)CC4
  • InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 checkY
  • Key:RGCVKNLCSQQDEP-UHFFFAOYSA-N checkY
  (verify)

Perfenazin adalah suatu obat antipsikotik tipikal. Secara kimia, obat ini diklasifikasikan sebagai piperazinil fenotiazina. Awalnya dipasarkan di Amerika Serikat dengan nama Trilafon. Obat ini telah digunakan secara klinis selama beberapa dekade.

Perfenazin kira-kira sepuluh kali lebih poten daripada klorpromazin pada reseptor dopamin-2 (D2);[2] sehingga perfenazin dianggap sebagai antipsikotik dengan potensi sedang.[3][4]

Referensi

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (dalam bahasa Brazilian Portuguese). Diário Oficial da União (dipublikasikan 2023-04-04). Diarsipkan dari versi aslinya tanggal 2023-08-03. Diakses tanggal 2023-08-16.
  2. ^ Rees L (August 1960). "Chlorpromazine and allied phenothiazine derivatives". British Medical Journal. 2 (5197): 522–5. doi:10.1136/bmj.2.5197.522. PMC 2097091. PMID 14436902.
  3. ^ Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J (February 2006). "Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia". BMC Psychiatry. 6 8. doi:10.1186/1471-244X-6-8. PMC 1402287. PMID 16504026.
  4. ^ Freudenreich O (2007). "Treatment of psychotic disorders". Psychotic disorders. Practical Guides in Psychiatry. Lippincott Williams & Wilkins. hlm. 88. ISBN 978-0-7817-8543-3. Diakses tanggal 2009-06-22.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Kembali kehalaman sebelumnya